**Core Concept**
Warfarin is an anticoagulant medication that exerts its effect through the inhibition of vitamin K-dependent clotting factors in the liver. It targets the gamma-carboxylation process, which is essential for the activation of these clotting factors.

**Why the Correct Answer is Right**
Warfarin inhibits the enzyme vitamin K epoxide reductase (VKOR), which is necessary for the recycling of vitamin K in the liver. This leads to a decrease in the production of vitamin K-dependent clotting factors (II, VII, IX, and X) and a subsequent prolongation of coagulation times. The inhibition of VKOR results in an accumulation of vitamin K epoxide, which in turn reduces the available vitamin K for the gamma-carboxylation of clotting factors.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect, as Warfarin does not directly inhibit the gamma-carboxylation process.
**Option B:** Incorrect, as Warfarin is not a direct inhibitor of the clotting factors themselves.
**Option C:** Incorrect, as Warfarin does not work through the inhibition of platelet aggregation.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the effect of Warfarin is dose-dependent and may take several days to develop, making it a crucial consideration in the management of patients requiring anticoagulation therapy.

**Correct Answer: C. Inhibition of vitamin K epoxide reductase (VKOR) leading to reduced production of vitamin K-dependent clotting factors.**